epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Egrifta WR
    tesamorelin

multicheck MultiCheck Results - 0 Interaction

Smiley face Smiley face

Additional Considerations

Smiley face Smiley face tesamorelin in Egrifta WR

caution advised with drugs metabolized by CYP450 liver enzymes; tesamorelin stimulation of growth hormone production may modulate CYP450 metabolic function, alter levels of concomitant drugs, incr. risk of adverse effects or decr. efficacy

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information